Stock HEALTH NIGHTINGALE HEALTH OYJ
Add to a list
To use this feature you must be a member
Log inSign up

Ratings Nightingale Health Oyj

Equities

HEALTH

FI4000490875

Delayed Nasdaq Helsinki
Other stock markets
 06:20:34 2024-05-02 am EDT 		5-day change 1st Jan Change
1.77 EUR -1.12% Intraday chart for Nightingale Health Oyj +5.36% +58.60%
Apr. 16 Finland’s Nightingale Health Plots US Expansion MT
Apr. 16 Nightingale Health to Establish A Laboratory in the United States CI

Summary

  • The company has strong fundamentals. More than 70% of companies have a lower mix of growth, profitability, debt and visibility.

Strengths

  • Analysts expect a sharply increasing business volume for the group, with high growth rates in the coming years.
  • Thanks to a sound financial situation, the firm has significant leeway for investment.
  • For the past year, analysts covering the stock have been revising their EPS expectations upwards in a significant manner.
  • For the past twelve months, EPS forecast has been revised upwards.
  • Over the past four months, analysts' average price target has been revised upwards significantly.
  • Analyst opinion has improved significantly over the past four months.
  • Over the past twelve months, analysts' opinions have been strongly revised upwards.

Weaknesses

  • As a percentage of sales and without taking into account depreciation and amortization, the company has relatively low margins.
  • The company's "enterprise value to sales" ratio is among the highest in the world.
  • For the last twelve months, the trend in sales revisions has been clearly going down, which emphasizes downgraded expectations from the analysts.
  • Revenue estimates are regularly revised downwards for the current and coming years.
  • The three month average target prices set by analysts do not offer high potential in comparison with the current prices.
  • The group usually releases earnings worse than estimated.

Ratings chart - Surperformance

Sector: Advanced Medical Equipment & Technology

1st Jan change Capi. Investor Rating ESG Refinitiv
NIGHTINGALE HEALTH OYJ Stock Nightingale Health Oyj
+58.60% 115M -
VEEVA SYSTEMS INC. Stock Veeva Systems Inc.
+3.31% 32.15B
C
PRO MEDICUS LIMITED Stock Pro Medicus Limited
+16.98% 7.41B
C-
SECTRA AB Stock Sectra AB
+21.38% 3.85B
B-
EVOLENT HEALTH, INC. Stock Evolent Health, Inc.
-17.44% 3.13B
C-
OMNICELL, INC. Stock Omnicell, Inc.
-27.80% 1.25B
B
LUNIT INC. Stock Lunit Inc.
-31.01% 1.17B -
B-SOFT CO.,LTD. Stock B-SOFT Co.,Ltd.
-34.81% 911M -
SIMULATIONS PLUS, INC. Stock Simulations Plus, Inc.
+3.51% 926M
C
VERADIGM INC. Stock Veradigm Inc.
-25.45% 842M -
C+
Investor Rating
Trading Rating
ESG Refinitiv
-

Financials

Sales growth
Earnings Growth
-
EBITDA / Sales
Profitability
-
Finances

Valuation

P/E ratio
-
EV / Sales
Price to Book
Price to Free Cash Flow
-
Yield
-

Momentum

1 year Revenue revision
4 months Revenue revision
7 days Revenue revision
1 year EPS revision
4 months EPS revision

Consensus

Analyst Opinion
Potential Price Target
4m Target Price Revision
4m Revision of opinion
12m Revision of opinion

Business Predictability

Analyst Coverage
Divergence of Estimates
-
Divergence of analysts' opinions
-
Divergence of Target Price
-
Earnings quality

Technical analysis

ST Timing
MT Timing
LT Timing
RSI
Bollinger Spread
Unusual volumes
  1. Stock Market
  2. Equities
  3. HEALTH Stock
  4. Ratings Nightingale Health Oyj